DK207575A - Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri - Google Patents
Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deriInfo
- Publication number
- DK207575A DK207575A DK207575A DK207575A DK207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A DK 207575 A DK207575 A DK 207575A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- active compounds
- medicinal product
- psychotropic effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2423389A DE2423389A1 (de) | 1974-05-14 | 1974-05-14 | Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK207575A true DK207575A (da) | 1975-11-15 |
Family
ID=5915522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK207575A DK207575A (da) | 1974-05-14 | 1975-05-12 | Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4053588A (da) |
| JP (1) | JPS50157361A (da) |
| BE (1) | BE829058A (da) |
| CA (1) | CA1067410A (da) |
| DE (1) | DE2423389A1 (da) |
| DK (1) | DK207575A (da) |
| FR (1) | FR2270867B1 (da) |
| GB (1) | GB1503680A (da) |
| IE (1) | IE41055B1 (da) |
| LU (1) | LU72449A1 (da) |
| NL (1) | NL7505479A (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1492640A (en) * | 1975-07-08 | 1977-11-23 | Ucb Sa | L-pyroglutamyl-l-prolinamide |
| EP0257084B1 (en) * | 1986-02-28 | 1990-12-27 | Hafslund Nycomed AS | Use of a dipeptide with cell growth regulating effect for the preparation of a medicament |
| IT1244548B (it) * | 1991-02-06 | 1994-07-15 | Poli Ind Chimica Spa | Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche |
| MXPA06001669A (es) | 2003-08-12 | 2006-04-28 | 3M Innovative Properties Co | Compuestos que contienen imidazo-oxima sustituidos. |
| US7897597B2 (en) | 2003-08-27 | 2011-03-01 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| WO2005023190A2 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| US8871782B2 (en) | 2003-10-03 | 2014-10-28 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| CA2545825A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| CA2545774A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Oxime substituted imidazo ring compounds |
| AU2004293078B2 (en) | 2003-11-25 | 2012-01-19 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
| EP1701955A1 (en) | 2003-12-29 | 2006-09-20 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| CA2551399A1 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| EP1730143A2 (en) | 2004-03-24 | 2006-12-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| WO2005123080A2 (en) | 2004-06-15 | 2005-12-29 | 3M Innovative Properties Company | Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| AU2005322898B2 (en) | 2004-12-30 | 2011-11-24 | 3M Innovative Properties Company | Chiral fused (1,2)imidazo(4,5-c) ring compounds |
| US20080119508A1 (en) * | 2004-12-30 | 2008-05-22 | 3M Innovative Properties Company | Multi-Route Administration Of Immune Response Modifier Compounds |
| JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| JP2008530113A (ja) | 2005-02-11 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法 |
| AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| WO2006107851A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| DE102014110783A1 (de) * | 2014-07-30 | 2016-02-04 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE63496C (de) * | B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien | Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes | ||
| US3002978A (en) * | 1958-05-06 | 1961-10-03 | Bocher Gustave Marie Joseph | Glyceryl pyrrolidone carboxylates |
| FR2207707A1 (en) * | 1972-11-27 | 1974-06-21 | Fabre Sa Pierre | 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity |
-
1974
- 1974-05-14 DE DE2423389A patent/DE2423389A1/de not_active Withdrawn
-
1975
- 1975-05-09 NL NL7505479A patent/NL7505479A/xx not_active Application Discontinuation
- 1975-05-12 DK DK207575A patent/DK207575A/da not_active Application Discontinuation
- 1975-05-12 GB GB19839/75A patent/GB1503680A/en not_active Expired
- 1975-05-12 LU LU72449A patent/LU72449A1/xx unknown
- 1975-05-12 US US05/576,715 patent/US4053588A/en not_active Expired - Lifetime
- 1975-05-13 IE IE1068/75A patent/IE41055B1/xx unknown
- 1975-05-13 CA CA227,257A patent/CA1067410A/en not_active Expired
- 1975-05-14 FR FR7515027A patent/FR2270867B1/fr not_active Expired
- 1975-05-14 BE BE156336A patent/BE829058A/xx unknown
- 1975-05-14 JP JP50056231A patent/JPS50157361A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE41055B1 (en) | 1979-10-10 |
| LU72449A1 (da) | 1977-02-09 |
| FR2270867B1 (da) | 1978-08-04 |
| JPS50157361A (da) | 1975-12-19 |
| GB1503680A (en) | 1978-03-15 |
| BE829058A (fr) | 1975-11-14 |
| NL7505479A (nl) | 1975-11-18 |
| IE41055L (en) | 1975-11-14 |
| US4053588A (en) | 1977-10-11 |
| DE2423389A1 (de) | 1975-12-04 |
| CA1067410A (en) | 1979-12-04 |
| FR2270867A1 (da) | 1975-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK207575A (da) | Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri | |
| DK524275A (da) | Stobt og sammenklemmelig oplosningsbeholder samt form til fremstilling af samme | |
| SE427323B (sv) | Engangsbloja | |
| SE432347B (sv) | Engangsbloja | |
| DK371277A (da) | Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning | |
| NL7413085A (nl) | Farmaceutisch en/of cosmetisch preparaat uitwendig gebruik. | |
| DK269175A (da) | Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin | |
| DK132519C (da) | Fremgangsmade til fremstilling af et stabilt medicinsk preparat indeholdende indomethacin samt beremedium til anvendelse ved fremgangsmaden | |
| DK222975A (da) | Fremgangsmade til fremstilling af polysocyanater og disses anvendelse | |
| DK150193C (da) | Fremgangsmaade til fremstilling af et amorft lactulosepulver til terapeutisk anvendelse | |
| FI772319A (fi) | Anordning foer orientering av med bindemedel foersedda lignocellulosahaltiga delar | |
| FI65910B (fi) | Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan | |
| DK132372C (da) | Fremgangsmade til fremstilling af tamponer og anleg til udovelse af fremgangsmaden | |
| DK248975A (da) | Fremgangsmade og farmaceutisk preparat til behandling af hypercholesterolemia | |
| DK548275A (da) | Peptider med blodtrykssenkende virkning og fremgangsmade til deres fremstilling | |
| IT1043490B (it) | Procedimento e dispositivo per la fabbricazione di pnfumatici | |
| RO72885A (ro) | Procedeu pentru prepararea unor halogen-acetamide nesaturate | |
| DK201275A (da) | Oplosninger af komplekse antimonforbindelser samt fremgangsmade til disses fremstilling og anvendelse | |
| DK144752C (da) | Dentalpulver og anvendelse deraf til fremstilling af tandfyldninger | |
| DK135997C (da) | 17alfa-hydroxy-1,3,5(10),15-ostratetraener til anvendelse sommellemprodukter for fremstilling af 15alfa,16alfa-methylen-4-ostren-17beta-oler og fremgangsmade til fremstilling af mellemprodukterne | |
| DK287176A (da) | Farmaceutisk kombinationspreparat og dets anvendelse | |
| DK529278A (da) | Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere | |
| DK326475A (da) | Fremgangsmade til fremstilling af nbetasubstituerede 8-beta-aminoethylergolin-iderivater og salte deraf | |
| DK137376A (da) | Fremgangsmade til fremstilling af farmaceutisk produkt indeholdende triamteren og cyclothiazid | |
| SE7713839L (sv) | Forfarande for framstellning av indanderivat med terapeutisk verkan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |